<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV) has been classically associated with nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, a monoclonal B-cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Since the EBV genome has also been found in post-transplant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> arising in individuals infected with the human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus, evidence has now accumulated that EBV might be the initiator of a multi-step process leading from polyclonal B-cell <z:mpath ids='MPATH_134'>hyperplasias</z:mpath> to monoclonal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In a retrospective study of 60 T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of various types, we found EBV DNA in 21 (35%) using Southern- and/or dot-blot techniques </plain></SENT>
<SENT sid="3" pm="."><plain>Eight of 14 nodal samples of angio-<z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> (57%) were shown to harbour detectable EBV DNA </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> with the next highest frequency, 47% (7/15 cases analyzed) was pleomorphic T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, medium- and large-cell type; EBV was found both in nodal and in extranodal <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of this type </plain></SENT>
<SENT sid="5" pm="."><plain>Lymphoepitheloid (<z:e sem="disease" ids="C1621719" disease_type="Neoplastic Process" abbrv="">Lennert</z:e>'s) <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and large-cell anaplastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were positive in 2/5 and 3/8, respectively, of the cases analyzed </plain></SENT>
<SENT sid="6" pm="."><plain>No <z:mp ids='MP_0001799'>viral</z:mp> DNA could be demonstrated in 3 T-<z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> and 5 T-lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Clonotypic analysis revealed monoclonal as well as oligoclonal virus populations </plain></SENT>
<SENT sid="8" pm="."><plain>Our data suggest that, at least in some of these entities, the presence of the EBV genome might be due to secondary mechanisms such as escape from immune surveillance </plain></SENT>
</text></document>